PLoS ONE (Jan 2015)

Genetic Ablation of CD38 Protects against Western Diet-Induced Exercise Intolerance and Metabolic Inflexibility.

  • Shian-Huey Chiang,
  • W Wallace Harrington,
  • Guizhen Luo,
  • Naphtali O Milliken,
  • John C Ulrich,
  • Jing Chen,
  • Deepak K Rajpal,
  • Ying Qian,
  • Tiffany Carpenter,
  • Rusty Murray,
  • Robert S Geske,
  • Stephen A Stimpson,
  • Henning F Kramer,
  • Curt D Haffner,
  • J David Becherer,
  • Frank Preugschat,
  • Andrew N Billin

DOI
https://doi.org/10.1371/journal.pone.0134927
Journal volume & issue
Vol. 10, no. 8
p. e0134927

Abstract

Read online

Nicotinamide adenine dinucleotide (NAD+) is a key cofactor required for essential metabolic oxidation-reduction reactions. It also regulates various cellular activities, including gene expression, signaling, DNA repair and calcium homeostasis. Intracellular NAD+ levels are tightly regulated and often respond rapidly to nutritional and environmental changes. Numerous studies indicate that elevating NAD+ may be therapeutically beneficial in the context of numerous diseases. However, the role of NAD+ on skeletal muscle exercise performance is poorly understood. CD38, a multi-functional membrane receptor and enzyme, consumes NAD+ to generate products such as cyclic-ADP-ribose. CD38 knockout mice show elevated tissue and blood NAD+ level. Chronic feeding of high-fat, high-sucrose diet to wild type mice leads to exercise intolerance and reduced metabolic flexibility. Loss of CD38 by genetic mutation protects mice from diet-induced metabolic deficit. These animal model results suggest that elevation of tissue NAD+ through genetic ablation of CD38 can profoundly alter energy homeostasis in animals that are maintained on a calorically-excessive Western diet.